NCT05977465View on ClinicalTrials.gov

Empagliflozin in Treatment of Peripheral Diabetic Neuropathy

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

January 20, 2022

Primary Completion Date

August 1, 2023

Study Completion Date

August 3, 2023

Conditions

Diabetic Neuropathy Peripheral

Interventions

DRUG

Empagliflozin 25 MG

treatment

Trial Locations (1)

31111

Faculty of pharmacy, Tanta

All Listed Sponsors

lead

Tanta University

OTHER